Acute West Nile virus in two patients receiving interferon and ribavirin for chronic hepatitis C [3]

American Journal of Gastroenterology

Volumn 99, Issue 5, 2004, Pages 957-

  Hrnicek, Matthew J ^a   Mailliard, Mark E ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; INTERFERON; PEGINTERFERON ALPHA2B; PEGYLATED INTERFERON ALPHA; RIBAVIRIN; UNCLASSIFIED DRUG; ALPHA2B INTERFERON;

ADULT; ANTIBODY TITER; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; ENCEPHALOMYELITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEVER; FLAVIVIRUS; HEADACHE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IN VITRO STUDY; INSECT BITE; LETTER; MALE; MOSQUITO; PREVALENCE; PRIORITY JOURNAL; RASH; UNITED STATES; VIRUS INFECTION; WEST NILE FLAVIVIRUS; ACUTE DISEASE; DRUG COMBINATION; FOLLOW UP; ISOLATION AND PURIFICATION; RISK ASSESSMENT;

ACUTE DISEASE; DRUG THERAPY, COMBINATION; FOLLOW-UP STUDIES; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2B; RIBAVIRIN; RISK ASSESSMENT; WEST NILE FEVER; WEST NILE VIRUS;

EID: 2942696609     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2004.40130.x     Document Type: Letter

References (5)

1. Centers for Disease Control and Prevention. West Nile virus activity-United States-October 30 to November 5, 2003. MMWR 2003;52:1080.
2. Morse DL. West Nile Virus: Not a passing phenomenon. N Engl J Med 2003;348:2173-4.
3. Dodd RY. Emerging infections, transfusion safety, and epidemiology. N Engl J Med 2003,349:1205-6.
4. Lucas M, Mashimo T, Frenkiel MP, et al. Infection of mouse neurones by West Nile virus is modulated by the interferon-inducible 2′-5′ oligoadenylate synthetase 1b protein. Immunol Cell Biol 2003;81:230-6.
5. Anderson J, Rahal J. Efficacy of interferon alpha-2b and ribavirin against West Nile virus in vitro. Emerg Infect Dis 2002;8:107-8.